-
Chinese (Simplified)
-
English
-
German
-
Korean
-
Spanish
Chinese (Simplified)
English
German
Korean
Spanish
Sign up for an account to enjoy easy online shopping and instant order tracking.
| Cat.No | ACP05788 | Target Name | ANKH |
|---|---|---|---|
| Form | Lyophilized powder | Expression System | Custom Production. Please inquire and provide the desire expression system. |
| Protein Length | Partial | Purity | >85% (SDS-PAGE) |
| Storage Buffer | 5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0. |
| Target Species | Human | Uniprot ID | Q9HCJ1 |
|---|
Uniprot Id
Q9HCJ1
Target Species
Human
Target Name
ANKH
Target Full Name
Mineralization regulator ANKH
Target Function
Regulates intra- and extracellular levels of inorganic pyrophosphate (PPi), probably functioning as PPi transporter.
Target Involvement
Chondrocalcinosis 2 (CCAL2); Craniometaphyseal dysplasia, autosomal dominant (CMDD)
Target Subcellular Location
Membrane; Multi-pass membrane protein.
Target Protein Families
ANKH family
Target Tissue Specificity
Found in osteoblasts from mandibular bone and from iliac bone; not detected in osteoclastic cells.
Target Synonyms
ANK; ANKH; ANKH_HUMAN; Ankylosis progressive homolog (mouse); Ankylosis progressive homolog; CCAL 2; CCAL2; CMDJ; CPPDD; Craniometaphyseal dysplasia Jackson type (dominant); FLJ27166; HANK; MANK; Progressive ankylosis protein homolog
Target Background
This gene encodes a multipass transmembrane protein that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. Progressive ankylosis-mediated control of pyrophosphate levels has been suggested as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals. Mutations in this gene have been associated with autosomal dominant craniometaphyseal dysplasia.
Notification